1. Anti-inflammatory effects of H2S during acute bacterial infection: a review
    Francesca Benedetti et al, 2017, J Transl Med CrossRef
  2. Respiratory explants as a model to investigate early events of contagious bovine pleuropneumonia infection
    Giovanni Di Teodoro et al, 2018, Vet Res CrossRef
  3. Current usage and effects of steroids in the management of childhood mycoplasma pneumonia in a secondary hospital
    Susie Yoo et al, 2018, Allergy Asthma Respir Dis CrossRef
  4. Extra-pulmonary diseases related to Mycoplasma pneumoniae in children
    Dimitri Poddighe, 2018, Current Opinion in Rheumatology CrossRef
  5. Grisel’s syndrome caused by Mycoplasma pneumoniae infection: a case report and review of the literature
    Raffaele Falsaperla et al, 2018, Childs Nerv Syst CrossRef
  6. Ameliorative Effects of Infantile Feire Kechuan Oral Solution on Mycoplasma Pneumoniae Pneumonia in Infant Mouse and Rat Models
    Shanshan Guo et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
  7. A Case of Influenza B and Mycoplasma pneumoniae Coinfection in an Adult
    Taro Shinozaki et al, 2018, Case Reports in Infectious Diseases CrossRef
  8. Mycoplasma contamination affects cell characteristics and decreases the sensitivity of BV2 microglia to LPS stimulation
    Nianhua Feng et al, 2019, Cytotechnology CrossRef
  9. Comparative evaluation of different therapeutic protocols for contagious caprine pleuropneumonia in Himalayan Pashmina goats
    Mohd. Iqbal Yatoo et al, 2019, Trop Anim Health Prod CrossRef
  10. Intravenous Immunoglobulin as a Therapeutic Option for Mycoplasma pneumoniae Encephalitis
    Mebratu Daba et al, 2019, J Child Neurol CrossRef
  11. Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis of Efficacy and Safety
    Qiao Li et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
  12. Association of the ACE, GSTM1, IL-6, NOS3, and CYP1A1 polymorphisms with susceptibility of mycoplasma pneumoniae pneumonia in Chinese children
    Jie Zhao et al, 2017, Medicine CrossRef
  13. Host Inflammatory Biomarkers of Disease Severity in Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis
    Catarina D Fernandes et al, 2019 CrossRef
  14. Mbov_0503 Encodes a Novel Cytoadhesin that Facilitates Mycoplasma bovis Interaction with Tight Junctions
    Xifang Zhu et al, 2020, Microorganisms CrossRef
  15. Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia
    Yinle Lan et al, 2020, Medicine CrossRef
  16. Contagious Bovine Pleuropneumonia: A Comprehensive Overview
    Giovanni Di Teodoro et al, 2020, Vet Pathol CrossRef
  17. The clinical significance of IL-6 s and IL-27 s in Bronchoalveolar lavage fluids from children with mycoplasma pneumoniae pneumonia
    Jie Zhao et al, 2020, BMC Infect Dis CrossRef
  18. Mycoplasma pneumoniae Genome Editing Based on Oligo Recombineering and Cas9-Mediated Counterselection
    Carlos Piñero Lambea et al, 2020, ACS Synth. Biol. CrossRef
  19. Effect of pidotimod combined with azithromycin on children with mycoplasma pneumonia and the expression levels of IL-10 and G-CSF in serum
    Hongxing Shi et al, 2019, Exp Ther Med CrossRef
  20. Epidemiology and molecular identification of mycoplasma pneumoniae associated with respiratory infections in Zhejiang province, China, 2008‐2017
    Qian Jiang et al, 2020, J Clin Lab Anal CrossRef
  21. Community-acquired pneumonia: aetiology, antibiotic resistance and prospects of phage therapy
    Md. Moinuddin Sheam et al, 2020, Journal of Chemotherapy CrossRef
  22. Recent progress and challenges on the bioassay of pathogenic bacteria
    Parinaz Babaie et al, 2020, J Biomed Mater Res CrossRef
  23. Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
    Fei Zhao et al, 2020, Front. Cell. Infect. Microbiol. CrossRef
  24. First report of macrolide resistant and susceptible Mycoplasma pneumoniae clinical strains isolated from one case
    Jing Li et al, 2021, Journal of Global Antimicrobial Resistance CrossRef
  25. Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development
    Zhulin Jiang et al, 2021, Pathogens CrossRef
  26. Maxing Shigan Decoction Mitigates Mycoplasma pneumonia-Induced Pyroptosis in A549 Cells via the NLRP3 Inflammasome
    Fang Liu et al, 2021, IDR CrossRef
  27. Correlations between Serum P2X7, Vitamin A, 25‐hydroxy Vitamin D, and Mycoplasma Pneumoniae Pneumonia
    Fanjun Meng et al, 2021, J Clin Lab Anal CrossRef
  28. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) moonlights as an adhesin in Mycoplasma hyorhinis adhesion to epithelial cells as well as a plasminogen receptor mediating extracellular matrix degradation
    Jia Wang et al, 2021, Vet Res CrossRef
  29. An AI-based auxiliary empirical antibiotic therapy model for children with bacterial pneumonia using low-dose chest CT images
    Mudan Zhang et al, 2021, Jpn J Radiol CrossRef
  30. SARS-CoV-2, Zika viruses and mycoplasma: structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases
    Gonzalo Ferreira et al, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  31. Engineering a genome‐reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo
    Victoria Garrido et al, 2021, Mol Syst Biol CrossRef
  32. Analysis of Clinical Characteristics and Risk Factors of Plastic Bronchitis in Children With Mycoplasma pneumoniae Pneumonia
    Haiqin Zhong et al, 2021, Front. Pediatr. CrossRef
  33. Mechanism of Infantile Feire Kechuan Oral Solution against Mycoplasma pneumoniae infection of A549 cells
    Ruijie Wan et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  34. Community-Acquired Respiratory Distress Syndrome Toxin: Unique Exotoxin for M. pneumoniae
    Xiaoling Su et al, 2021, Front. Microbiol. CrossRef
  35. Mycoplasma pneumoniae and Chlamydia pneumoniae Coinfection with Acute Respiratory Distress Syndrome: A Case Report
    Meng-Ko Tsai et al, 2021, Diagnostics CrossRef
  36. Metabolomic Analysis Reveals Potential Biomarkers and the Underlying Pathogenesis Involved in Mycoplasma Pneumoniae Pneumonia
    Jieqiong Li et al, 2022, Emerging Microbes & Infections CrossRef
  37. Pseudomembranous necrotizing laryngotracheobronchitis due to Mycoplasma pneumoniae: a case report and literature review
    Wu Lei et al, 2022, BMC Infect Dis CrossRef
  38. Mycoplasma pneumoniae Pleural Effusion in Adults
    Chang Ho Kim et al, 2022, JCM CrossRef
  39. Exploring the mechanism of Qinbaiqingfei-concentrate pills in the treatment of Mycoplasma pneumoniae pneumonia from the perspective of intestinal microbiota and mucosal immunity
    Zheng Liu et al, 2022, Journal of Ethnopharmacology CrossRef
  40. The Severity of the Co-infection of Mycoplasma pneumoniae in COVID-19 Patients
    Rohit Rangroo et al, 2022 CrossRef
  41. Cell damage and neutrophils promote the infection of Mycoplasma pneumoniae and inflammatory response
    Zhikun Zhang et al, 2022, Microbial Pathogenesis CrossRef
  42. Novel mycoplasma nucleomodulin MbovP475 decreased cell viability by regulating expression of CRYAB and MCF2L2
    Gang Zhao et al, 2022, Virulence CrossRef
  43. Children with Mycoplasma pneumoniae infection in Taiwan: Changes in molecular characteristics and clinical outcomes
    Jo-Ching Charlotte Hsiung et al, 2022, Journal of the Formosan Medical Association CrossRef
  44. Apigenin suppresses mycoplasma-induced alveolar macrophages necroptosis via enhancing the methylation of TNF-α promoter by PPARγ-Uhrf1 axis
    Xiuzhen Mei et al, 2022, Phytomedicine CrossRef
  45. Risk Factors for the Development of Post-Infectious Bronchiolitis Obliterans in Children: A Systematic Review and Meta-Analysis
    Eun Lee et al, 2022, Pathogens CrossRef
  46. Comprehensive virome analysis of the viral spectrum in paediatric patients diagnosed with Mycoplasma pneumoniae pneumonia
    Qiong Guo et al, 2022, Virol J CrossRef
  47. Insight into the Pathogenic Mechanism of Mycoplasma pneumoniae
    Jie Hu et al, 2023, Curr Microbiol CrossRef
  48. Serum cytokine profiling reveals different immune response patterns during general and severe Mycoplasma pneumoniae pneumonia
    Zhikun Zhang et al, 2022, Front. Immunol. CrossRef
  49. Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections
    Armando S. Flores-Torres et al, 2022, Front. Allergy CrossRef
  50. Aspergillus oryzae Fermentation Extract Alleviates Inflammation in Mycoplasma pneumoniae Pneumonia
    Hui-Yu Lee et al, 2023, Molecules CrossRef
  51. Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia
    Yacui Wang et al, 2023, Emerging Microbes & Infections CrossRef
  52. Mycoplasma pneumoniae: Among the smallest bacterial pathogens with great clinical significance in children
    Surinder Kumar et al, 2023, Indian Journal of Medical Microbiology CrossRef
  53. Primary symptoms of severe mycoplasma pneumoniae pneumonia with acute abdomen, scrotal swelling and pain, and fever: A case report
    Hui Lei et al, 2023, Immunity Inflam & Disease CrossRef
  54. Investigating the occurrence of autoimmune diseases among children and adolescents hospitalized for Mycoplasma pneumoniae infections
    Eun Kyo Ha et al, 2023, Front. Immunol. CrossRef
  55. Necroptosis in Pneumonia: Therapeutic Strategies and Future Perspectives
    Xiuzhen Mei et al, 2024, Viruses CrossRef
  56. Mycoplasma infection aggravates cardiac involvements in Kawasaki diseases: a retrospective study
    Guoyan Lu et al, 2024, Front. Immunol. CrossRef
  57. Extracellular vesicles as tools and targets in therapy for diseases
    Mudasir A. Kumar et al, 2024, Sig Transduct Target Ther CrossRef
  58. Association between Mycoplasma pneumoniae infection, high‑density lipoprotein metabolism and cardiovascular health (Review)
    Tao Shen et al, 2024, Biomed Rep CrossRef
  59. Research on the metabolic regulation mechanism of Yangyin Qingfei decoction plus in severe pneumonia caused by Mycoplasma pneumoniae in mice
    Tianyu Zhang et al, 2024, Front. Pharmacol. CrossRef
  60. Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019
    Yue Jiang et al, 2024, Epidemiol. Infect. CrossRef
  61. Rotavirus Hospitalization in Early Childhood: Fine Motor Skills and Cognition at 6 Years Old in a Population-Based Cohort Study
    Eun Kyo Ha et al, 2024 CrossRef